Clinical Prognostic Score to Predict Relapse in VL

This prospective cohort study has the aim to develop a prognostic tool to predict relapse in patients suffering from visceral leishmaniasis (VL) from VL endemic regions in Ethiopia.Therefore, comprehensive clinical and laboratory characterization of all confirmed VL patients before and during treatment will be performed in order to identify the factors that determine prognosis of the patients. This approach would result in more efficient patient care and would reduce the case fatality and morbidity, and improve follow-up and care for those at risk of VL relapse.

Inclusion Criteria:clinically or parasitologically confirmed VLExclusion Criteria:Age under 12 yearsVL patients already on treatment for 3 days or moreSevere critical condition or other circumstances that make the study medically inadvisableUnlikely to adhere to follow up visits during the study period (e.g. patients who live or work very far away) AND not reachable by phone for follow-up informationPregnant or lactating woman